Page last updated: 2024-11-05

tiopronin and Cardiomyopathies

tiopronin has been researched along with Cardiomyopathies in 2 studies

Tiopronin: Sulfhydryl acylated derivative of GLYCINE.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kilgore, KS1
Homeister, JW1
Satoh, PS1
Lucchesi, BR2
Simpson, PJ1
Mickelson, JK1

Reviews

1 review available for tiopronin and Cardiomyopathies

ArticleYear
Free radical scavengers in myocardial ischemia.
    Federation proceedings, 1987, May-15, Volume: 46, Issue:7

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Allopurinol; Cardiomyopathies; Catalas

1987

Other Studies

1 other study available for tiopronin and Cardiomyopathies

ArticleYear
Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury.
    The American journal of physiology, 1994, Volume: 266, Issue:1 Pt 2

    Topics: Animals; Captopril; Cardiomyopathies; Complement System Proteins; Coronary Circulation; Enalaprilat;

1994